Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Meta is warning that cybercriminals are tricking people into downloading programs that can steal valuable information on fake ChatGPT offers. Cheddar News explains how Meta has observed hundreds of malicious links on its platform.
The 11,500 members of the Writers Guild of America went on strike this week after negotiations with Hollywood studios that began in March failed to result in an agreement.
Will McDonough, founder and CEO of EMG Advisors, joined Cheddar News to discuss Wednesday's trading session after the Federal Reserve raised rates by 0.25% as tighter credit conditions continue to affect small- and medium-sized businesses.
The Federal Reserve reinforced its fight against high inflation Wednesday by raising its key interest rate by a quarter-point to the highest level in 16 years.
Cheddar News' Courtney Sturgeon reports from the Cboe floor with Alan Knuckman, Chief Market Strategist at Bulls Eye Option, to discuss strategies for options traders ahead of a busy trading week amid earnings, the FOMC meeting, and more.
